A best evidence topic in surgery was written according to a structured protocol. The question addressed was how elective laparoscopic abdominal aortic aneurysm (AAA) repair compared to endovascular aneurysm repair (EVAR) in terms of survival. There were 229 papers found using the reported search, with 8 papers (5 prospective studies, 1 retrospective study, 1 randomized trial and 1 systematic review) representing the best evidence to answer the question proposed. Current evidence suggests that EVAR is the preferred surgical approach for AAA repair, due to shorter hospital stay and lower perioperative morbidity and mortality rates, as opposed to an open surgical approach. Despite this, EVAR is subject to a number of limitations, including device restrictions in patients with anatomical variations as well as increased risk of future complications stemming from device implantation. We discuss a key study that showed that complications in the EVAR group commonly included endoleak type II and graft thrombosis. More importantly, there were similar rates of complications between those patients receiving EVAR and those receiving minimally invasive aortic surgery. The evidence suggests that elective laparoscopic AAA repair has a favourable safety profile comparable with that of EVAR, with low conversion rates as well as similar mortality and morbidity rates. This has been illustrated in several studies. We discuss a prospective randomized trial of 100 patients, which compared EVAR with hand-assisted laparoscopic surgery. This study showed no deaths in either group after the procedure or at follow-up after 12 months, with similar complication rates between the groups. While the evidence suggests that EVAR is less invasive, it does not always significantly alter the postoperative course or length of hospital stay for patients. We conclude from the evidence available that elective laparoscopic AAA repair may have a role in those patients who are unsuitable for EVAR. Unfortunately, few studies exist directly comparing these two techniques, and those that do are subject to limitations, for example, study population bias, small sample sizes and a lack of comparison in the literature between the common AAA repair techniques.
INTRODUCTION
A best evidence topic was constructed according to a structured protocol. This has been fully described in the ICVTS [1] . 
Three-part question

Clinical scenario
You are at a multidisciplinary team meeting discussing a patient with a potentially operable AAA. One of the surgeons offers to perform this procedure as an elective laparoscopic AAA repair, while another surgeon argues the case for EVAR. Intrigued by the most appropriate surgical approach, you consult the literature to determine which approach is superior in terms of survival, an elective laparoscopic AAA repair approach or EVAR.
Search strategy
Medline search 1990-13 using the PubMed interface for the terms: ('abdominal aortic aneurysm ' 
Search outcome
There were 229 papers found using the reported search. From these, eight papers were identified that provided the best evidence to answer the question. This includes five prospective studies, one retrospective study, one randomized trial and one systematic review, as presented in Table 1 .
RESULTS
Kolvenbach et al. [2] in a 2001 prospective cohort study (n = 40) demonstrated that hand-assisted laparoscopic surgery (HALS) could be offered to those patients who were deemed unsuitable for EVAR. A total of 24 patients received HALS and 13 patients received EVAR, with 3 excluded from the study [2] . HALS was achieved through transperitoneal access, which involved a midline mini-incision and the use of a HandPort to allow for aneurysm repair thereafter. There was 1 death in the HALS group vs 0 deaths in the EVAR group [2] . There were also four complications reported in each group, with a morbidity of 16.6% in HALS vs 30.7% in EVAR [2] . Those patients who received EVAR were transferred less frequently to intensive care unit (ICU) compared with HALS (P < 0.001) [2] . Surprisingly, there was no significant difference seen between the length of hospital stay and mobilization between the two groups.
Tefera et al. [3] conducted a retrospective study (n = 84) comparing EVAR against minimal incision aortic surgery (MIAS) in patients who met high-risk criteria and had infrarenal aneurysms. A total of 84 patients were assessed, with 61 patients receiving EVAR and 23 patients receiving MIAS. Patients were assigned to a particular group on the basis of exclusionary criteria or patient choice if both options were available. Every procedure was performed with a bifurcated endograft system or standard Dacron prosthetic. In the EVAR group, there were 2 (3%) deaths (resulting from multiorgan failure) vs 1 (4%) death (resulting from an MI) in the MIAS group [3] . The 30-day morbidity was 11 (18%) patients in those receiving EVAR vs 4 (17%) patients receiving MIAS, with the average duration of stay being 5.1 days for both groups [3] . Unfortunately, there were no significant differences in morbidity and mortality between the two groups, with the P-value unspecified.
Turnipseed et al. [4] performed a prospective cohort study comparing 70 EVAR patients against 96 MIAS patients. MIAS involved a small midline incision, followed by retraction of the small bowel using a Bookwalter retractor and open hand-sewn anastomoses. In the EVAR group, there were 2 (2.8%) deaths vs 2 (2.1%) deaths in the MIAS group [4] . In terms of morbidity, there were 14 cardiac, 5 embolic, 1 ileus, 9 pulmonary and 4 non-specified complications in the EVAR group vs 3 cardiac, 3 embolic, 2 ileus, 2 pulmonary and 8 non-specified complications in the MIAS group [4] . However, both mortality and morbidity rates did not differ significantly between the two groups, with P-values unspecified. The mean hospital stay for EVAR was 2 days vs 4.8 days for MIAS, which yet again did not reach significance [4] . Interestingly, the only statistical significance was in the cost of service delivery, which was −$7263 for EVAR and +$8445 for MIAS (P < 0.001) [4] .
Veroux et al. [5] performed a prospective randomized trial of 100 patients, evaluating the incidence of sexual dysfunction between those patients treated by EVAR and HALS. HALS was achieved by a minilaparotomy incision with Omniport insertion. Conversely, EVAR involved endograft placement (Talent or Endurant) below the renal artery. There were 50 patients assigned to the EVAR group vs 50 patients in the HALS group. There were no reported deaths in either group during the procedure or at follow-up after 12 months [5] . In terms of morbidity, the EVAR group contained 4 cases of type 1 endoleak and 3 cases of type 2 endoleak [5] . Conversely, the HALS group had 2 patients develop laparosceles, which is defined as a herniation through the abdominal wall. The mean length of stay was 3.4 days for EVAR vs 4.2 days for HALS, though, again, this did not reach statistical significance [5] .
Ferrari et al. [6] in 2006 conducted a consecutive case study, which reported the outcomes of 122 AAA repairs using HALS. HALS was achieved through a midline minilaparotomy incision allowing Omniport introduction and anastomosis formation between the aorta and Dacron prosthesis. Contraindications for HALS included peritonitis, bowel perforation, obstruction and distension, previous aortoiliac surgery, severe cardiovascular disease (including an ejection fraction of <35%) as well as logistic factors. Juxtarenal AAAs and obesity were not considered as contraindications. There were no recorded deaths when using the HALS approach or at follow-up (28.6 ± 16 months), with an overall morbidity rate of 12.2%, which included bleeding and leg-graft thrombosis [6] . This study also looked at the learning curve effect of HALS, dividing patients into two groups and comparing the first 30 cases with the last 92 cases, and demonstrating significantly shorted cross-clamping, total operating times and shorter hospital stay.
Javerliat et al. [7] performed a prospective study in 239 patients who were treated laparoscopically. They then further identified a subgroup of 99 patients, with standard surgical risk, who presented with AAAs compatible with EVAR. In this subgroup, no deaths occurred during the procedure, but there were 3 'severe' complications, 10 'moderate' complications and 4 'local' complications which developed [7] . Intensive care unit stay and the length of hospital stay were 24 h and 6 days, respectively [7] .
Coggio et al. [8] in 2008 analysed a cohort of 148 patients undergoing total laparoscopic AAA repair. This included a subset of 13 patients (12 males and 1 female) who underwent laparoscopic juxtarenal AAA repair, with tube grafts implanted in 9 patients and bifurcated grafts in 4 patients [8] . Juxtarenal AAA repair was a transperitoneal retrorenal approach using either tube grafts or bifurcated grafts. No patients died during the procedure or at the 19-month follow-up [8] . In terms of morbidity, 1 patient developed a postoperative coagulopathy, 4 developed renal insufficiencies and 1 developed ischaemic colitis [8] .
Clinical conclusion
From reviewing the eight best evidence articles, we conclude that laparoscopic surgery is just as safe as EVAR, as demonstrated by similar mortality and morbidity rates as well as length of hospital stay in the studies discussed. Moreover, elective laparoscopic AAA repair could potentially be used for those patients who are unable to receive EVAR. Overall, this conclusion should be taken cautiously, as laparoscopic surgery is still subject to a number of limitations, including longer operative times, required operator experience and improvements in laparoscopic surgical tools. Single-centred, prospective randomized trial, with a 12-month follow-up period 100 patients were eligible for AAA repair and randomized to one of two groups: EVAR (n = 50) vs HALS (n = 50)
The outcomes of the two groups were assessed
Outcomes measured included the incidence of sexual dysfunction, mortality, morbidity as well as length of hospital stay
Patients in the HALS group had a younger median age than those in the EVAR group at 61 vs 69 years, respectively (P = 0.002) Mortality: there were no deaths in either group during the procedure or at the 12-month follow-up Morbidity: 3 (6%) patients in EVAR vs 2(4%) patients in the HALS group reported erectile dysfunction (P-value was not significant)
There were also 2 patients in the HALS group developed laparoceles, one of whom needed surgical repair. In the EVAR group, 2 patients developed a graft thrombosis. There were also four type 1 endoleaks and three type 2 endoleaks that occurred in the EVAR group Respiratory complications were rare in both groups (HALS (0%) vs EVAR (1%)
This study concluded that HALS could be a minimally invasive alternative for sexually active males who are unsuitable for EVAR. This study also demonstrates low mortality rates and comparable rates of morbidity between the two procedures 
